Published in J Infect Dis on August 18, 2003
Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection. AIDS (2014) 0.96
High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction. BMC Infect Dis (2016) 0.80
Recognition of group D streptococcal species of human origin by biochemical and physiological tests. Appl Microbiol (1972) 13.09
Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N Engl J Med (1985) 11.94
Physiological differentiation of viridans streptococci. J Clin Microbiol (1977) 11.17
Genotypic identification of rickettsiae and estimation of intraspecies sequence divergence for portions of two rickettsial genes. J Bacteriol (1991) 9.65
Presumptive identification of group A, B, and D streptococci. Appl Microbiol (1974) 8.23
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med (2000) 8.05
Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun (1973) 7.01
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med (2000) 6.58
Emergence of drug-resistant pneumococcal infections in the United States. JAMA (1994) 6.29
A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med (1993) 6.18
Comparison of several laboratory media for presumptive identification of enterococci and group D streptococci. Appl Microbiol (1973) 6.17
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Near-fatal heat stroke during the 1995 heat wave in Chicago. Ann Intern Med (1998) 6.03
Presumptive identification of group D streptococci: the bile-esculin test. Appl Microbiol (1970) 6.00
Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71
Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med (1993) 5.45
Clonal nature of Salmonella typhi and its genetic relatedness to other salmonellae as shown by multilocus enzyme electrophoresis, and proposal of Salmonella bongori comb. nov. J Clin Microbiol (1989) 5.21
Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis. J Clin Microbiol (1992) 5.20
The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med (1995) 5.18
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA (2001) 4.90
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63
The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis (1999) 4.37
Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. J Infect Dis (1991) 4.00
Nonhemolytic group B streptococci of human, bovine, and ichthyic origin. Infect Immun (1973) 3.81
Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis (2001) 3.68
Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA (1995) 3.64
Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ (1992) 3.57
Changing epidemiology of group A streptococcal infection in the USA. Lancet (1990) 3.35
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA (1993) 3.31
The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis (1996) 3.26
Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J Infect Dis (1998) 3.18
Phylogenetic analysis of some Aerococcus-like organisms from clinical sources: description of Helcococcus kunzii gen. nov., sp. nov. Int J Syst Bacteriol (1993) 3.16
Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species. J Clin Microbiol (1984) 3.16
Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis (1999) 3.15
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09
Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA (1991) 3.09
Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Antimicrob Agents Chemother (1974) 3.06
Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) (1970) 3.05
The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis (1992) 3.04
Reduction in the incidence of human listeriosis in the United States. Effectiveness of prevention efforts? The Listeriosis Study Group. JAMA (1995) 2.97
Evaluation of 10 methods to distinguish epidemic-associated Campylobacter strains. J Clin Microbiol (1991) 2.97
Aspergillosis and other systemic mycoses. The growing problem. JAMA (1979) 2.96
Evaluation of commercial latex agglutination reagents for grouping streptococci. J Clin Microbiol (1979) 2.95
Efficacy of meningococcal vaccine and barriers to vaccination. JAMA (1998) 2.92
Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol (2001) 2.92
Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl Environ Microbiol (1990) 2.90
Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis (1996) 2.85
Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med (1980) 2.85
Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group. JAMA (1992) 2.82
Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis (1990) 2.80
Risk factors for group B streptococcal disease in adults. Ann Intern Med (1995) 2.78
Presumptive identification of group A, B, and D streptococci on agar plate media. J Clin Microbiol (1979) 2.72
Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J Clin Microbiol (1992) 2.67
Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet (1991) 2.63
Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol (1994) 2.63
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health (2000) 2.57
Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis (1999) 2.57
Presumptive identification of streptococci with a new test system. J Clin Microbiol (1982) 2.55
Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? J Clin Microbiol (1989) 2.51
On the use of zero-inflated and hurdle models for modeling vaccine adverse event count data. J Biopharm Stat (2006) 2.45
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Haemophilus influenzae meningitis. A national study of secondary spread in household contacts. N Engl J Med (1979) 2.34
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun (1993) 2.32
Analysis of Listeria monocytogenes by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Int J Food Microbiol (1989) 2.29
Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med (1986) 2.26
Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol (1992) 2.23
Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21
Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr (1996) 2.17
Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group. JAMA (1992) 2.15
Granulicatella and Abiotrophia species from human clinical specimens. J Clin Microbiol (2001) 2.14
Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J Infect Dis (1998) 2.11
Specificity study of kits for detection of group A streptococci directly from throat swabs. J Clin Microbiol (1987) 2.10
Legionnaires' disease: clinical features of the epidemic in Philadelphia. Ann Intern Med (1979) 2.10
The 1997 AAP guidelines for prevention of early-onset group B streptococcal disease. American Academy of Pediatrics. Pediatrics (1997) 2.04
Rapid identification of enterococci. J Clin Microbiol (1983) 2.03
Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clin Diagn Lab Immunol (1995) 2.00
The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol (1996) 1.99
Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Bull World Health Organ (1999) 1.96
Comparison of ribotyping and multilocus enzyme electrophoresis for subtyping of Listeria monocytogenes isolates. J Clin Microbiol (1994) 1.96
Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother (1990) 1.93
Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis (1995) 1.93
Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med (1999) 1.92
Phenotypic and genotypic characterization of atypical Lactococcus garvieae strains isolated from water buffalos with subclinical mastitis and confirmation of L. garvieae as a senior subjective synonym of Enterococcus seriolicida. Int J Syst Bacteriol (1996) 1.92
Differentiation of Lactococcus lactis and Lactococcus garvieae from humans by comparison of whole-cell protein patterns. J Clin Microbiol (1991) 1.91
The gram positive cocci. Hum Pathol (1976) 1.90
emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci. Microbiology (2000) 1.89
Meningococcal disease in Los Angeles County, California, and among men in the county jails. N Engl J Med (1996) 1.89
Neonatal enterococcal sepsis: case-control study and description of an outbreak. Pediatr Infect Dis J (1987) 1.89
Robust estimation of standard curves for protein molecular weight and linear-duplex DNA base-pair number after gel electrophoresis. Anal Biochem (1986) 1.88
Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis (2002) 1.84